鼻咽癌抗独特型抗体疫苗的研究进展
被引量:1
Progress in Anti-idiotype Antibody Vaccine for Nasopharyngeal Carcinoma
摘要
抗独特型抗体因可模拟肿瘤抗原,打破免疫耐受,已应用于卵巢癌、乳腺癌、黑色素瘤、结肠癌、淋巴瘤、胰腺癌等多种肿瘤的综合治疗中,并已取得一定疗效。文章就抗独特型抗体在鼻咽癌免疫治疗中的应用及发展趋势作一综述。
出处
《肿瘤学杂志》
CAS
2008年第1期23-26,共4页
Journal of Chinese Oncology
参考文献20
-
1Reinartz S,Boerner H,Kohler S,et al.Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines.A preliminary report[J].Hybridoma,1999,18(1):41-45.
-
2Wagner U,Siegmund K,Reinartz S.Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125:immune responses and survival in palliative treatment[J].Clin Cancer Res,2001,7(5):1154-1162.
-
3Koprowski HD,Herlyn ML,Freitas ED,et al.Human antiidiotype antibodies in cancer patients:is the modulation of the immune response beneficial for the patient?[J].Proc Nat Acad Sci USA,1984,81(1):216-219.
-
4Sun QB,Guo M,Li XL,et al.Production and identification of monoclonal antibodies against nasopharyngeal carcinoma (NPC)[J].Bull Human Med Coll,1987,12(1):1-3.
-
5李官成,谢鹭,孙去病.鼻咽癌抗独特型单克隆抗体的主动免疫初探[J].中国肿瘤生物治疗杂志,1997,4(4):273-277. 被引量:2
-
6杨剑飞,王飒,李小玲,郭敏,李官成,孙去病.鼻咽癌抗独特型单克隆抗体的制备和鉴定[J].标记免疫分析与临床,1994,1(2):79-83. 被引量:2
-
7李官成,朱建高,周国华,孙去病.体内体外联合免疫法制备抗鼻咽癌单克隆抗体[J].湖南医学,1999,16(5):326-328. 被引量:2
-
8李官成,谢鹭,符红普,周国华,朱建高,周建华,孙去病.鼻咽癌抗独特型疫苗的制备及临床研究[J].中国癌症杂志,2000,10(3):193-197. 被引量:8
-
9何小鹃,李官成,朱建高,李跃辉,周国华.鼻咽癌人源抗独特型单链抗体的制备及筛选[J].癌症,2004,23(2):124-129. 被引量:13
-
10汪静,李官成,童永清,张志杰.鼻咽癌人源抗独特型基因工程抗体的原核表达及鉴定[J].中国现代医学杂志,2008,18(8):1056-1059. 被引量:4
二级参考文献34
-
1李官成,孙去病.肿瘤相关抗原CA-Hb_3对大肠癌血清学诊断的价值[J].中国肿瘤临床,1996,23(3):173-177. 被引量:4
-
2刘启才,方嬿,李晓艳,柳息洪,曾益新.NP9蛋白的原核表达及纯化[J].中国现代医学杂志,2005,15(23):3556-3558. 被引量:1
-
3孙去病 郭敏 李小玲等.鼻咽癌的单克隆抗体研究:杂交瘤细胞系的建立及初步鉴定[J].湖南医学院学报,1987,12(1):1-3.
-
4Jerne NK. Towards a network theory, of the immune system [J] .Ann Immunol(Paris), 1974, 125C(1 -2): 373 -389.
-
5Foon KA, Lutzky J, Baral RN, et al. Clinical and immune response in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2 [J]. J Clin Oncol,2000, 18(2): 376 - 384.
-
6Li G, Xie L, Zhou G, et al. A clinical trail of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients[J]. Chin Med J, 2002, 115(4): 567 - 570.
-
7Cai X, Garen A. Anti-melonoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-ehain Fv fusion phage libraries [J]. Proc Natl Acad Sci USA, 1995, 92(14):6537 -6541.
-
8Durrant LG, Buckley DJ, Spendlove I, et al. Low dose of 105AD7 cancer vaccine preferentially stimulate anti-tumor T-cell immunity[J]. Hybridoma, 1997, 16(1 ): 23 - 26.
-
9Tripathi PK, Qin H, Deng S, et al. Antigen mimicry by an anti-idiotypic antibody single chain variable fragment [J]. Mol Immunol, 1998, 35(13): 853 - 863.
-
10Reinartz S, Wagner U, Giffels P, et al. Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACAI25 [J].Cancer Immunol Immunother, 2000, 49 (4 - 5 ) : 186 - 192.
共引文献18
-
1黄建,肖艳,童永清,郭锋杰,周国华,李跃辉,胡锦跃,李官成.全人源抗肝癌噬菌体单链抗体的筛选与鉴定[J].细胞与分子免疫学杂志,2008,24(3):256-259. 被引量:5
-
2舒峻,李官成,何小鹃.人鼻咽癌组织定向cDNA文库的构建[J].中国耳鼻咽喉颅底外科杂志,2004,10(4):200-203.
-
3汪静,李官成(审校).抗独特型疫苗在肿瘤免疫治疗中的研究现状及前景[J].国际免疫学杂志,2006,29(4):221-225. 被引量:3
-
4郑鑫,夏青娟,朱世成,郝林琳,姜海龙,宋海龙,龙淼,王哲.猪生长激素抗独特型抗体的制备及免疫学鉴定[J].中国兽医学报,2006,26(5):516-518. 被引量:3
-
5王业荣,童德文,李立,刘文明,王业炳.人源化抗体制备及其应用研究进展[J].生物技术通讯,2007,18(4):683-687. 被引量:7
-
6罗晨,何小鹃,赵艳,张志杰,李官成.人源性鼻咽癌抗独特型单链抗体基因G22真核表达载体的构建及表达鉴定[J].中南大学学报(医学版),2008,33(1):16-20.
-
7汪静,李官成,童永清,张志杰.鼻咽癌人源抗独特型基因工程抗体的原核表达及鉴定[J].中国现代医学杂志,2008,18(8):1056-1059. 被引量:4
-
8段红,庞华,尹晓玲,彭志平,李少林.全人源食管癌噬菌体单链抗体库的筛选及特异性鉴定[J].中国肿瘤临床,2008,35(12):714-717. 被引量:1
-
9肖艳,李官成,李跃辉,黄建,童永清,张志杰.全人源抗肝癌噬菌体单链抗体库的构建与筛选鉴定[J].生物化学与生物物理进展,2008,35(8):947-953. 被引量:2
-
10许静,朱晓娟,顾春艳,李红,戴洋,李玉华,仇镇宁,管晓虹,朱荫昌,冯振卿.日本血吸虫抗独特型抗体NP30对急性血吸虫病的免疫治疗作用[J].中国血吸虫病防治杂志,2009,21(3):187-192.
同被引文献11
-
1Abdolreza (Reza) Movahedi, David J. Hampton, New ways to identify novel bacterial antigens for vaccine development [J ]. Veterinary Microbiology,2008,131 : 1 - 13.
-
2Sandro Vivona. Computer aided biotechnology: from immuno informaties to reverse vaccinology [ J ] . Trends in Biotechnology, 2008,26 (4).
-
3Marirosa Mora. Reverse vaccinology[J ]. Research focus, 2003.
-
4Rino Rappuoli, Antonello Covacci, Reverse Vaccinology and Genomics [J ]. Science,2003, 302,602.
-
5Davide Serruto. Genome based approaches to develop vaccines against bacterial pathogens[J 1. Vaccine, 2009,27 : 3245 - 3250.
-
6Jeffrey B. Ulmer. Note influenza DNA vaccines[J ] .Vaccine, 2002, 20 : 74 - 76.
-
7Heather L. Davis, Michael J. McCluskie. DNA vaccines for viral diseases[J].Microbes and Infection, 1999, 1:7 21.
-
8Shisong Jiang. Overlapping synthetic peptides as vaccines[J ] . Vaccine,2006, 24:6356-6365.
-
9Saied Mirshahidi. Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival [J ]. Vaccine, 2009, 27:1825 - 1833.
-
10赵占中,薛飞群,杨素珍,陈贵锐.DNA疫苗的优化策略[J].中国生化药物杂志,2009,30(3):206-208. 被引量:1
-
1沈倍奋.免疫毒素的临床应用及发展趋势[J].单克隆抗体通讯,1993,9(3):12-15. 被引量:1
-
2周少雄,肖桂元.抗独特型肿瘤疫苗的研究现状及前景[J].中国肿瘤生物治疗杂志,1998,5(2):145-147.
-
3刘剑勇,李挺.肿瘤疫苗的研究进展[J].中国医学文摘(肿瘤学),2000,14(4):322-324. 被引量:1
-
4聂建梅,谷春霞,张振龙(综述).肿瘤疫苗的研究进展[J].国际生物制品学杂志,2011,34(2):86-90.
-
5张晓辉,孙强.乳腺癌疫苗的研究进展[J].中华临床医师杂志(电子版),2012,6(12):134-135. 被引量:2
-
6吕方芳,洪小南,李进.树突状细胞疫苗研究进展[J].中国癌症杂志,2004,14(1):86-89. 被引量:1
-
7黄薇,李力,田厚文.子宫颈癌人乳头状瘤病毒疫苗的研究进展[J].国外医学(病毒学分册),2003,10(3):70-74.
-
8阎玉英,樊婷婷.HPV疫苗的研究进展[J].首都医药,2012,19(4):23-24. 被引量:1
-
9吴勉云,伍欣星,邱惠.HPV相关肿瘤疫苗的研究进展[J].肿瘤防治杂志,2003,10(1):21-23. 被引量:2
-
10杨博萍,李力.人乳头瘤病毒疫苗的研究进展及前景[J].中国妇幼健康研究,2010,21(6):839-841. 被引量:4